158 related articles for article (PubMed ID: 34707406)
1. LncRNA PTCSC3 and lncRNA HULC Negatively Affect Each Other to Regulate Cancer Cell Invasion and Migration in Gastric Cancer [Retraction].
Cancer Manag Res; 2021; 13():8003-8004. PubMed ID: 34707406
[TBL] [Abstract][Full Text] [Related]
2. LncRNA PTCSC3 and lncRNA HULC Negatively Affect Each Other to Regulate Cancer Cell Invasion and Migration in Gastric Cancer.
Cai Y; Li Y; Sun B; Wang H; Zhang W; Zhao Y; Zhao H; Zhang J; Xu J; Wang Y
Cancer Manag Res; 2020; 12():8535-8543. PubMed ID: 32982446
[TBL] [Abstract][Full Text] [Related]
3. LncRNA PTCSC3 Alleviates the Postoperative Distant Recurrence of Gastric Cancer by Suppression of lncRNA HOXA11-AS.
Xu J; Zhang Y; You Q; Fu H; Zhao X; Lu K; Yan R; Yang D
Cancer Manag Res; 2020; 12():2623-2629. PubMed ID: 32368140
[TBL] [Abstract][Full Text] [Related]
4. LncRNA PTCSC3 Is a Biomarker for the Treatment and Prognosis of Gastric Cancer.
Zhang G; Chi N; Lu Q; Zhu D; Zhuang Y
Cancer Biother Radiopharm; 2020 Feb; 35(1):77-81. PubMed ID: 31702383
[No Abstract] [Full Text] [Related]
5. LncRNA PTCSC3 inhibits the proliferation, invasion and migration of cervical cancer cells via sponging miR-574-5p.
Tong R; Zhang J; Wang C; Li X; Yu T; Wang L
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):439-448. PubMed ID: 31587336
[TBL] [Abstract][Full Text] [Related]
6. LncRNA PTCSC3 Inhibits Tumor Growth and Cancer Cell Stemness in Gastric Cancer by Interacting with lncRNA Linc-pint.
Hong L; Wang H; Wang J; Wei S; Zhang F; Han J; Liu Y; Ma M; Liu C; Xu Y; Jiang D
Cancer Manag Res; 2019; 11():10393-10399. PubMed ID: 31849528
[TBL] [Abstract][Full Text] [Related]
7. Novel lncRNA LINC01614 Facilitates Bladder Cancer Proliferation, Migration and Invasion Through the miR-217/RUNX2/Wnt/β-Catenin Axis [Retraction].
Cancer Manag Res; 2022; 14():2105-2106. PubMed ID: 35769227
[TBL] [Abstract][Full Text] [Related]
8. LncRNA PTCSC3 inhibits triple-negative breast cancer cell proliferation by downregulating lncRNA H19.
Wang N; Hou M; Zhan Y; Sheng X
J Cell Biochem; 2019 Sep; 120(9):15083-15088. PubMed ID: 31026090
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
Xia S; Ji R; Zhan W
BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
[TBL] [Abstract][Full Text] [Related]
10. LncRNA PTCSC3 inhibits cell proliferation in laryngeal squamous cell carcinoma by down-regulating lncRNA HOTAIR.
Xiao D; Cui X; Wang X
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31171714
[TBL] [Abstract][Full Text] [Related]
11. MiR-488 suppresses cell proliferation and invasion by targeting ADAM9 and lncRNA HULC in hepatocellular carcinoma [Retraction].
Am J Cancer Res; 2020; 10(12):4643. PubMed ID: 33415025
[TBL] [Abstract][Full Text] [Related]
12. Long Non-Coding RNA HULC Promotes Progression of Bone Neoplasms.
Zhang T; Wan CY; Mei XL; Jia P; Wang MJ
Med Sci Monit; 2018 Aug; 24():5754-5760. PubMed ID: 30120220
[TBL] [Abstract][Full Text] [Related]
13. LncRNA HLA Complex Group 11 Knockdown Alleviates Cisplatin Resistance in Gastric Cancer by Targeting the miR-144-3p/UBE2D1 Axis [Retraction].
Cancer Manag Res; 2023; 15():979-980. PubMed ID: 37693223
[TBL] [Abstract][Full Text] [Related]
14. METase/lncRNA HULC/FoxM1 reduced cisplatin resistance in gastric cancer by suppressing autophagy.
Xin L; Zhou Q; Yuan YW; Zhou LQ; Liu L; Li SH; Liu C
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2507-2517. PubMed ID: 31485766
[TBL] [Abstract][Full Text] [Related]
15. LncRNA ASB16-AS1 Promotes Growth and Invasion of Hepatocellular Carcinoma Through Regulating miR-1827/FZD4 Axis and Activating Wnt/β-Catenin Pathway [Retraction].
Cancer Manag Res; 2022; 14():501-502. PubMed ID: 35177934
[TBL] [Abstract][Full Text] [Related]
16. LncRNA EMX2OS Induces Proliferation, Invasion and Sphere Formation of Ovarian Cancer Cells via Regulating the miR-654-3p/AKT3/PD-L1 Axis [Retraction].
Cancer Manag Res; 2024; 16():67-68. PubMed ID: 38282793
[TBL] [Abstract][Full Text] [Related]
17. Retraction notice for: "Effect of lncRNA HULC knockdown on rat secreting pituitary adenoma GH3 cells" [Braz J Med Biol Res (2019) 52(4): e7728].
Braz J Med Biol Res; 2020; 53(9):e7728retraction. PubMed ID: 32756812
[TBL] [Abstract][Full Text] [Related]
18. The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma.
Chen S; Wu DD; Sang XB; Wang LL; Zong ZH; Sun KX; Liu BL; Zhao Y
Cell Death Dis; 2017 Oct; 8(10):e3118. PubMed ID: 29022892
[TBL] [Abstract][Full Text] [Related]
19. MiR-625 Inhibits Tumor Cell Invasion, Migration and EMT by Negatively Regulating the Expression of Resistin in Non-Small Cell Lung [Retraction].
Cancer Manag Res; 2023; 15():1341-1342. PubMed ID: 38027242
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HOTAIRM1 Inhibits the Proliferation and Invasion of Lung Adenocarcinoma Cells via the miR-498/WWOX Axis [Retraction].
Cancer Manag Res; 2024; 16():65-66. PubMed ID: 38282791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
